68.10
price up icon2.79%   1.85
 
loading

Arcellx Inc 주식(ACLX)의 최신 뉴스

pulisher
01:45 AM

FY2026 EPS Estimates for Arcellx Lifted by Leerink Partnrs - Defense World

01:45 AM
pulisher
Jun 06, 2025

Squarepoint Ops LLC Sells 4,670 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Arcellx FY2029 EPS Forecast Raised by Leerink Partnrs - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Top NASDAQ Stocks Arcellx’s Role by Kalkine - Kalkine Media

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Acquires 1,100 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Sells 945 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 03, 2025
pulisher
May 31, 2025

How to Take Advantage of moves in (ACLX) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 29, 2025

Nuveen Asset Management LLC Sells 9,110 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Arcellx Inc Holds Annual Stockholders Meeting - TipRanks

May 28, 2025
pulisher
May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga

May 23, 2025
pulisher
May 22, 2025

Thinking Of Buying Arcellx Inc (NASDAQ: ACLX) Stock? Here’s What You Need To Know - Stocksregister

May 22, 2025
pulisher
May 21, 2025

Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Business Wire

May 21, 2025
pulisher
May 21, 2025

Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Bluefield Daily Telegraph

May 21, 2025
pulisher
May 21, 2025

Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday - Benzinga

May 21, 2025
pulisher
May 20, 2025

Baron Discovery Fund Initiated a Position in Arcellx (ACLX) - Insider Monkey

May 20, 2025
pulisher
May 19, 2025

BNP Paribas Financial Markets Makes New $1.53 Million Investment in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 19, 2025
pulisher
May 16, 2025

Arcellx Inc (ACLX) Receives a Buy from Canaccord Genuity - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Mercer Global Advisors Inc. ADV Takes $278,000 Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 16, 2025
pulisher
May 16, 2025

Arcellx, Inc. Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Arcellx Inc’s Anito-cel Shows Promising Results in Phase 2 Trial, Earning Buy Rating from Analyst - TipRanks

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald Expects Reduced Earnings for Arcellx - Defense World

May 15, 2025
pulisher
May 14, 2025

Insiders At Arcellx Sold US$2.6m In Stock, Alluding To Potential Weakness - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Promising Clinical Data and Strong Safety Profile Lead to Buy Rating for Arcellx Inc’s Anito-cel - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx Inc’s Anito-cel Shows Promising Efficacy and Safety in Multiple Myeloma, Earning Buy Rating - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx's Potential Multiple Myeloma Treatment Shows 97% Overall Response Rate in Phase 2 Study; Shares Rise - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Promising Clinical Trial Results and Safety Profile Support Buy Rating for Arcellx Inc’s Anito-cel Therapy - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx Announces Positive Phase 2 Study Results - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma - BioSpace

May 14, 2025
pulisher
May 14, 2025

Arcellx Reports Positive Data From Phase 2 IMMagine-1 Study - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Arcellx announces data from iMMagine-1 study of anitocabtagene autoleucel - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx, Inc. Announces New Positive Data for Its Immagine-1 Study in Patients with Relapsed And/Or Refractory Multiple Myeloma - marketscreener.com

May 14, 2025
pulisher
May 12, 2025

Arcellx Inc.: Strong Financial Position and Promising Phase 2 Study Outcomes Drive Buy Rating - TipRanks

May 12, 2025
pulisher
May 12, 2025

Here’s Why Arcellx (ACLX) Declined in Q1 - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

Arcellx, Inc. (NASDAQ:ACLX) Receives $109.31 Average Target Price from Brokerages - Defense World

May 12, 2025
pulisher
May 11, 2025

Scotiabank Has Lowered Expectations for Arcellx (NASDAQ:ACLX) Stock Price - Defense World

May 11, 2025
pulisher
May 10, 2025

Piper Sandler Remains a Buy on Arcellx Inc (ACLX) - The Globe and Mail

May 10, 2025
pulisher
May 10, 2025

Arcellx Inc (ACLX) Receives a Buy from Scotiabank - The Globe and Mail

May 10, 2025
pulisher
May 10, 2025

Arcellx First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Needham Sticks to Their Buy Rating for Arcellx Inc (ACLX) - The Globe and Mail

May 10, 2025
pulisher
May 10, 2025

Arcellx (ACLX) Maintains Rating as Price Target is Lowered by Sc - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Arcellx price target lowered to $93 from $133 at Scotiabank - TipRanks

May 10, 2025
pulisher
May 09, 2025

Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

Promising Potential of Arcellx Inc’s Anito-cel Therapy: A Buy Rating Backed by Positive Study Data and Strategic Trial Enhancements - TipRanks

May 09, 2025
pulisher
May 09, 2025

Arcellx (ACLX): Scotiabank Adjusts Price Target Amid Regulatory Concerns | ACLX Stock News - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Arcellx’s Promising Trial Results and Strategic Partnerships Justify Buy Rating with $121 Target - TipRanks

May 08, 2025
pulisher
May 08, 2025

Arcellx Inc. Receives Buy Rating: Strong Financial Outlook and Promising Data Catalysts - TipRanks

May 08, 2025
pulisher
May 08, 2025

Promising Potential of Arcellx Inc’s Anito-cel Program Drives Buy Rating - TipRanks

May 08, 2025
pulisher
May 08, 2025

ARCELLX Earnings Results: $ACLX Reports Quarterly Earnings - Nasdaq

May 08, 2025
pulisher
May 08, 2025

Earnings Flash (ACLX) ARCELLX INC. Reports Q1 Revenue $8.1M, vs. FactSet Est of $19.5M - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Arcellx Provides First Quarter 2025 Financial Results and Business Highlights - Business Wire

May 08, 2025
pulisher
May 08, 2025

Before Buying Arcellx Inc (NASDAQ: ACLX) Stock, Read This First - Stocksregister

May 08, 2025
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):